Forget roads and water, Karnataka polls a battle between Hindus and Muslims: BJP MLA

Mangaluru, Feb 2: A local court on Saturday remanded Aditya Rao,the suspect in the Mangaluru International Airport (MIA) bomb case, to two weeks judicial custody.

Rao was produced before the Sixth Judicial First Class Magistrate Court after the 10-day police custody expired.

Rao has been in police custody since January 22 after he surrendered before the police in Bengaluru on January 21 and was later brought here.

He had allegedly planted an Improvised Explosive Device (IED) at the airport on January 20 triggering panic and later made a hoax call to the airport terminal that a bomb had been planted in an IndiGo flight.

During the last ten days, police took the accused to several places in the city and Udupi where he had frequented in the recent past.

He was also taken to the room where he stayed while he was working at a hotel in the city.

Mangaluru, Jul 23: A nurse who was serving as a frontline COVID warrior at the Wenlock Hospital in Mangaluru and has recently tested positive along with her 7-year-old son has complained to the Deputy Commissioner against the harassment meted out by some miscreants who have been spreading false rumours against her.

Health official said that some people in her area have given false complaints against her to government officials thus inflicting mental torture on her and her family.

In her letter, the nurse has stated that the attitude of the people forcing her to consider quitting the job. "I have served the people by treating my work as worship. Anti-social elements have been torturing me now. I am very much hurt," the she said. 

The nurse’s house at Moodbidri has been sealed after she was tested positive. However, her husband and younger child were tested negative.

Bengaluru, Mar 27: Oncologist Dr. Vishal Rao, HCG Hospital Bengaluru on Friday said that human body cells release interferon chemical to kill viruses but it cannot be released by cells in the case of COVID-19 cases, leading to weak immune system. However, a therapy of specific concoction could be useful in treating COVID-19 patients.

"We got hold of some preprint suggesting that interferon is effective in COVID19," said Rao.

Speaking to news agency, he continued saying "When we withdraw blood for regular check-ups, we get buffy coat which can be used to take out cells and form interferon. These two chemicals and some other cytokines, in a specific concoction, could be potentially very useful in treating COVID-19 patients."

Rao said that they have built a concoction of cytokines which can be injected to reactivate immune system in COVID-19 patients.

"We are in a very initial stage and hope to be ready with its first set by this weekend. We have applied to the governement for an expedited review. We have also presented this before the state government" said Rao.

"We have a team of infection specialist, ICU team and other...all of us have worked together to build something that we believe. We want to serve the society at this hour of need," he added.

Dr Rao clarified that this is not a vaccine and this particular interferon therapy does not help to prevent the infection of COVID-19. However, this is focused and targeted towards COVID-19 positive patients or those who have just incubated the virus.

"We believe that in early stages as well as the patients who have just incubated, this particular therapy of interferon gama and other concoction of cytokines could be an effective method. In the late stages we are looking at specific dosage of the cells which are our own body cells which can actually be affective and could also be of use for the ventilator patients," he added.

Meanwhile, Dr Gururaj, Immunologist and Scientist told ANI that they are trying to cover two aspects, one is the early stage patients where they are trying to improve their immune systems.

"As Dr Vishal said, we are trying to see whether we can use the cytokines from our own immune cells which is a natural process but it is hampered in infected patients," said Dr Gururaj.

"In the last phase we are using cells which are used from the bone marrow of the patient or donors. We can use those cells to reduce the inflation and so called cytokines release syndrome which is basically the inflammatory response of the body," he added.